Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 07-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Sales | 3,639 | 3,639 | 2,476 | 2,280 | 1,703 |
| Cost of Goods | 1,958 | 1,958 | 4,213 | 1,846 | 1,120 |
| Gross Profit | 1,682 | 520 | -1,737 | 434 | 583 |
| Operating Expenses | 2,218 | 2,218 | 213 | 2,102 | 1,331 |
| Operating Income | 422 | 422 | -1,737 | -822 | -628 |
| Interest Expense | 0 | 30 | 93 | 57 | 0 |
| Other Income | 2,458 | 2,488 | 227 | 321 | -15 |
| Pre-tax Income | 2,879 | 2,879 | -1,604 | -558 | -643 |
| Income Tax | N/A | 0 | 49 | 30 | 21 |
| Net Income Continuous | 2,919 | -1,160 | -1,571 | -588 | -641 |
| Net Income | $2,919 | $2,919 | $-1,571 | $-588 | $-641 |
| EPS Basic Total Ops | 0.49 | -0.21 | -0.27 | -0.10 | 0.34 |
| EPS Basic Continuous Ops | 0.49 | -0.19 | -0.27 | -0.10 | -0.11 |
| EPS Diluted Total Ops | 0.49 | -0.21 | -0.27 | -0.10 | 0.34 |
| EPS Diluted Continuous Ops | 0.49 | -0.19 | -0.27 | -0.10 | -0.11 |
| EBITDA(a) | $623 | $472 | $-1,587 | $-492 | $-442 |